Tillotts Pharma specialises in one area of therapy, diseases of the lower gastrointestinal tract.
The products that Tillotts is responsible for treat two disease conditions:

* inflammatory bowel disease (IBD)
* irritable bowel syndrome (IBS)

SALES & MARKETING
Tillotts markets two brands:

* Asacol®, which through the efforts of licensees and distributors has become the leading product worldwide for the treatment of Inflammatory Bowel Disease (IBD), consisting of Crohn's disease and ulcerative colitis, and
*
Colpermin®, a naturally based remedy for the treatment of symptoms of Irritable Bowel Syndrome (IBS).

5-ASA
Asacol
Colpermin
Crohn's disease
Epanova
IBD
IBS
Inflammatory bowel disease
Irritable bowel syndrome
Mesalazine
Peppermint oil
Tillotts
Ulcerative Colitis
Topasa

Tillotts is a small, fast growing pharmaceutical company based near Basel, in Switzerland.

  ASACOL  
     
 
  Thanks to its sophisticated delivery system Tillotts’ ASACOL (Mesalazine) is the first choice drug for the treatment of Ulcerative Colitis and is also widely used in Crohn’s Disease.

 

Tillotts' ASACOL for IBD is successfully introduced in over 44 countries. We are now looking for Distribution Partners in Latin America and Pan-Asia (excl. Japan & Korea).If your company has good contact to Gastroenterologists and Asacol would fit to your existing GI product portfolio, then please contact our Business & Development department for further information.

If you have a pharmaceutical product or possess marketing and distribution capability in the digestive area, please send your proposal to Tillotts for consideration (email: epierpaoli@tillotts.com).

Asacol®, Colpermin®, Topasa® and Xenema® are Trade Marks or registered Trade Marks of Tillotts Pharma AG.
    
© 2007 by tillotts pharma ag – all rights reserved | designed by senger interactive
   fotos: image100 (visual) | tillotts pharma ag